Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
24.68
+0.57 (2.36%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pediatrix Medical Group stock have an average target of 23.33, with a low estimate of 19 and a high estimate of 27. The average target predicts a decrease of -5.47% from the current stock price of 24.68.
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +1.30% | May 12, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | -2.76% | May 8, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $23 | Hold | Maintains | $23 | -6.81% | May 6, 2026 |
| William Blair | William Blair | Buy Reiterates $22 | Buy | Reiterates | $22 | -10.86% | May 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $24 → $27 | Buy | Maintains | $24 → $27 | +9.40% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
1.94B
from 1.91B
Increased by 1.30%
Revenue Next Year
1.99B
from 1.94B
Increased by 2.53%
EPS This Year
2.28
from 2.04
Increased by 11.58%
EPS Next Year
2.36
from 2.28
Increased by 3.66%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9B | 2.0B | |
| Avg | 1.9B | 2.0B | |
| Low | 1.9B | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6% | 4.2% | |
| Avg | 1.3% | 2.5% | |
| Low | 0.6% | 1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.37 | 2.59 | |
| Avg | 2.28 | 2.36 | |
| Low | 2.17 | 2.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.2% | 13.8% | |
| Avg | 11.6% | 3.7% | |
| Low | 6.4% | -6.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.